Dayana B Rivadeneira

4PUBLICATIONS
70CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 21, 2025
Tumour interstitial fluid-enriched phosphoethanolamine suppresses T cell function.

Yupeng Wang, Drew Wilfahrt, Patrick Jonker

|Nov 08, 2024
Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism.

Ronal M Peralta, Bingxian Xie, Konstantinos Lontos

|Aug 08, 2023
An oncolytic virus-delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment.

Kristin DePeaux, Dayana B Rivadeneira, Konstantinos Lontos

|Sep 27, 2022
Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma.

Andrew W Hahn, Ashley V Menk, Dayana B Rivadeneira

Pageof 1

Frequent Collaborators

4 joint publications

Greg M Delgoffe

2 joint publications

William G Gunn

1 joint publications

Andrew W Hahn

1 joint publications

Ashley V Menk